Patrick F. Kelly

This profile gathers the share dealings of Patrick F. Kelly in Forma Therapeutics Holdings, Inc., where the filings describe the role as senior executive. In total, 9 filings cover trades dated from 23 June 2020 to 8 April 2022.

On the open market, the record shows 1 purchase and 4 sales worth €45k. No amount is published for 4 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 1 option exercise. So far in 2022, the count stands at no purchases and 1 sale.

The newest entry dates from 14 April 2022: an option exercise of €70k, in Forma Therapeutics Holdings, Inc. The last insider purchase was made public on 24 June 2020, 2,329 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.